- Grants since 2016
- 611
- Awarded, last 5 years (where amounts are published)
- €94.6M
- Funded works, last 5 years
- 5 837
- Funded works, all time
- 8 569
Grants
2026–2028 · grant
Personalized, targeted therapy for RASopathies by Inhibition of protein-protein interactions of the SHP2 phosphatase.
Gianfranco Bocchinfuso · University of Rome Tor Vergata
2026–2028 · grant
Deciphering and exploiting the regulatory logic of Tbx1 gene expression.
Antonio Baldini · National Research Council
2026–2028 · grant
Oligodendrocyte progenitor cell-based therapy in a primary autosomal recessive microcephaly-17 (MCPH17) preclinical model: optimization and mechanisms
Enrica Boda · Istituto Di Neuroscienze Cavalieri Ottolenghi
2026–2028 · grant
Molecular therapeutic approaches for NEDAMSS syndrome
Ferdinando Fiumara · University of Turin
2026–2027 · grant
Mechanosensitive regulation of the GABAergic switch in Jamuar syndrome.
Fabio Falleroni · Ospedale Policlinico San Martino - Irccs
2026–2029 · grant
TREating Arrhythmogenic cardiomyopathy by Targeting neuropeptide-Y signaliNG
Tania Zaglia
2026–2029 · grant
EMPOWERING MUSCULAR DYSTROPHY TREATMENT: EXPLORING THE POTENTIAL OF IDENTIFIED COMPOUND TO TARGET NUCLEAR FACTOR 1 X
Graziella Messina · University of Milan
2026–2028 · grant
Gene-corrected stem-cell models to reverse the immune phenotypes in ICF syndrome, a rare inborn error of immunity
Maria Rosaria Matarazzo · National Research Council
2026–2029 · grant
Stratifying SYNGAP1 Mutations to Develop Patient-Specific Targeted Therapeutic Strategies
Bernadette Basilico · Sapienza University of Rome
2026–2029 · grant
Brain-Targeted Biodegradable Nanoparticles for Innovative Fragile X Therapy
Claudia Bagni · University of Rome Tor Vergata
2026–2029 · grant
Melatonin MT2-Selective Agonists as a Novel Treatment for Fragile X Syndrome (FXS) and Phelan McDermid Syndrome (PMS)
Stefano Comai · University of Padua
2026–2029 · grant
Unravelling the role of NOVA splicing factors in cerebellar neurodegeneration associated to spinocerebellar ataxia type 37
Simona Rossi · National Research Council
2026–2027 · grant
Emerging pathways of neurodegeneration in Sanfilippo syndrome
Elvira De Leonibus · Telethon Institute Of Genetics And Medicine (tigem)
2026–2029 · grant
Preclinical validation of a novel drug for treating Wolfram syndrome and Type 2A Charcot-Marie-Tooth disease.
Carmen Abate · University of Bari Aldo Moro
2026–2028 · grant
Characterizing TMEM63B: a novel mechanosensitive ion channel coding gene whose mutations cause developmental and epileptic encephalopathy with white matter abnormalities
Valerio Conti · Azienda Ospedaliera Universitaria Meyer Irccs
2026–2029 · grant
Repairing SERCA1 with CFTR Correctors: Innovative Zebrafish Model for Brody Myopathy Therapy (RESTORE)
Roberta Sacchetto · University of Padua
2026–2027 · grant
Long-term therapeutic and mechanistic evalUation of metformiN in zebrafish and pAtient-derived cell models for NCLs diseases (LUNA)
Maria Marchese · Fondazione Stella Maris - Irccs
2026–2028 · grant
Illuminating dark gene targets through coevolution
Riccardo Percudani · University of Parma
2026–2028 · grant
Investigating the impact of the lamina-associated TDark network on chromatin architecture dysfunction in Emery-Dreifuss Muscular Dystrophy
Francesco Ferrari · National Research Council
2026–2027 · grant
STRIDE-DMD - Uncover STK11IP Role in trIggering fibrosis anD mEchanical-metabolic uncoupling in Duchenne muscular dystrophy
Brigida Boccanegra · University of Bari Aldo Moro
2026–2029 · grant
Liver involvement in hereditary lysozyme (ALys) amyloidosis: dissecting molecular mechanisms of disease (The LIALA study)
Stefano Ricagno · University of Milan
2026–2028 · grant
Molecular Insights into the Role of the Ripply3 Gene in DiGeorge Syndrome and Related Disorders.
Daniela Alfano · National Research Council
2026–2027 · grant
Investigating DDX3Y compensatory mechanism in DDX3X-related syndrome
Alfredo Brusco · University of Turin
2026–2029 · grant
A NOVEL THERAPEUTIC APPROACH TARGETING PRO-RESOLVING MECHANISMS IN THE CARDIOMYOPATHY OF SICKLE CELL DISEASE
Lucia De Franceschi · University of Verona
2026–2027 · grant
Glancing at TTI2's role in the context of Autosomal Recessive Intellectual Developmental disorder
Luca Murru · National Research Council
2026–2029 · grant
Exploring the role of HSPB3 in chromatin remodeling for neuromuscular junction maintenance: implications for peripheral motor neuropathies
Serena Carra · Università Degli Studi Di Modena E Reggio Emilia Unimore
2026–2028 · grant
Molecular characterisation of the Dark gene Fbxo34 as a suppressor of mutant Huntingtin toxicity
Graziano Martello · University of Padua
2026–2027 · grant
Hidden Players in Sensory Deficits: ‘Dark’ Odorant Receptors in the Fragile X Syndrome
Claudia Bagni · University of Rome Tor Vergata
2026–2029 · grant
Repurposing a panel of Late Sodium Current Blockers for pharmacological targeting of Familial hemiplegic migraine 3: a dual-approach ex vivo study.
Paola Gavazzo · National Research Council
2026–2027 · grant
Molecular and functional in vivo characterization of telo2-interacting protein 2 (tti2) during zebrafish embryonic development
Pietro Cacialli · University of Bologna
2026–2027 · grant
Exploring the role of RSPRY1 in osteogenesis to unravel the pathogenic mechanisms of Spondyloepimetaphyseal Dysplasia, Faden-Alkuraya Type
Elisa Lazzari · University of Trieste
2025–2026 · grant
Spatially resolved transcriptomic analysis of cardiac architecture in Anderson-Fabry disease: identification of novel pathogenetic mechanisms
Irene Salamon · Irccs Azienda Ospedaliero-universitaria Di Bologna
2025–2027 · grant
Targeting the mitochondrial enzyme monoamine oxidase B to treat mucopolysaccharidoses: a drug repurposing strategy
Marcella Canton · University of Padua
2025–2027 · grant
Transition to adulthood in people with dystrophy: social cognition mechanisms, psychosocial adjustment, and mental health and coping strategies.
Maria Grazia D'Angelo · Associazione La Nostra Famiglia Eugenio Medea - Irccs
2025–2027 · grant
Unravelling the role of the Polycomb Group Protein BMI1 in Cerebral Cavernous Malformations
Massimiliano Pagani · Ifom Ets - Istituto Fondazione Di Oncologia Molecolare
2025–2027 · grant
Uncovering Glycoprotein and Deregulated Gene Targets in OGT-Linked Intellectual Disability
Matthieu Boulard · European Molecular Biology Laboratory
2025–2027 · grant
Defective metabolism of sialo-conjugates in Huntington's disease is a druggable target for the development of new effective therapeutic strategies
Vittorio Maglione · Fondazione Neuromed
2025–2027 · grant
Rescuing PNPase defects in bacterial and human cell models (RESPNP)
Federica Briani · University of Milan
2025–2027 · grant
EEC-Clear: towards customized allele-specific CRISPR/Cas gene editing for the treatment of ocular surface disorder in EEC syndrome
Laura De Rosa · Università Degli Studi Di Modena E Reggio Emilia Unimore
2025–2027 · grant
ENGINEERING PROBIOTICS FOR THE SAFE DELIVERY OF THERAPEUTIC PROTEINS IN THE TREATMENT OF RARE NEURODEVELOPMENTAL DISORDERS
Elisabetta Ciani · University of Bologna